Ark Restaurants Stock Ticker Symbol ARKR Exchange: NASDAQ
Top 10 Most Recent News Articles
Rocket Companies' Earnings Preview: What's at Stake?
Anticipation Builds Around Rocket's Earnings Call It ain't every day that a company's earnings announcement stirs up interest the way Rocket Companies' (NYSE:RKT) upcoming third-quarter results have. But here we are, just days away from October 29, 2026, when leadership will lay out the cards at 4:30 p.m. ET. This announcement might just be what investors like us need to...
Continue Reading
Rich McLaughlin Takes Helm of WFUV Radio
A Familiar Face Steers the Ship at WFUV There's something about returning to your roots that often feels like coming home. For Rich McLaughlin, taking over as general manager of WFUV is like slipping into a well-worn pair of shoes. He's known the rhythms and quirks of this place since his college days at Fordham, and now he's at the helm, guiding this beloved New York...
Continue Reading
TBL Carves New Path with New York License Win
Punching Through to New Opportunities Folks, here's one for the record books: the Team Boxing League (TBL) just nabbed the promoter license from the New York State Athletic Commission, or NYSAC if you're into the alphabet soup. This isn't just paperwork getting shuffled around an office; it's a massive leap forward for team boxing, a sport that steps into the heart of New...
Continue Reading
Paolo Moretti: New CEO Steering RINA's Dynamic Course
Leadership Shift in the Heart of RINA Today's news is a hefty dose of strategic sea change over at RINA S.p.A., where Paolo Moretti's been handed the reins as the new Group Chief Executive Officer. Now, if you haven't been following, RINA's been riding a serious wave—revenues have more than doubled in a neat five-year streak, claiming over a billion euros. So, what we...
Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT
A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...
Continue ReadingJJ Lin's Iconic Singapore Grand Prix Show With 20 Songs
Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...
Continue Reading
Volvo's Q3 2026 Results: Strong Growth and Margin
Volvo Group's Robust Q3 Performance It's not every day that you see a company like Volvo Group churning out results that make you take a second sip of that morning coffee. But here we are—looking at Q3 2026 with growth numbers that pack a punch. You can't argue with SEK 119.5 billion in net sales, especially when organic sales growth hit 7%. That's no small feat in...
Continue Reading
Baccarat's Luxe Campaign Courts the High-End Traveler
Shining the Spotlight on a Crystal-Clear Vision When Baccarat decides to cast its net over the high-end travel market, they're not doing it with subtlety. Nope, they're going all out, and why wouldn't they? When you've got a brand that's synonymous with luxury, you have to play the part. Enter Adriana Lima, the supermodel who could probably sell sand in the Maldives if...
Continue Reading
Align™ Unveils Stylish Yet Sturdy Footwear for Fall
New Season, New Style: Align™ Hits the Mark Align™ is rolling out its Fall-Winter 2026 men's footwear lineup, and if you're looking for styles that marry form with function, you're in for a treat. Launched just a year ago under the umbrella of H.H. Brown, Align's guns are blazing with a collection set to make some noise in the footwear world. Stepping Into Fall: Fresh...
Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence
Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...
Continue ReadingTop 5 Most Recently Viewed Articles
Innovative Partnership Boosts MoviePass's Growth with Sui
Exploring the Sui and MoviePass Partnership The collaboration between Sui Foundation and MoviePass marks an exciting development in the way technology is transforming the moviegoing experience. Known for its innovations in blockchain, Sui Foundation has teamed up with MoviePass to improve its services, especially in the U.S. movie market. USDC Payment System Integration A...
Continue Reading
Leadership Changes at National Press Club Journalism Institute
New Leadership at the National Press Club Journalism Institute In a significant move for journalism support, Ed Kelley has been appointed as the president of the National Press Club Journalism Institute for the term 2025-26. With a rich background in local media and academia, Kelley aims to continue the mission of empowering journalists to better serve their communities....
Continue Reading
Investors Warned of Potential Fraud at MoonLake Immunotherapeutics
Concerns Over MoonLake Immunotherapeutics and Investor Trust Investors have raised alarms regarding MoonLake Immunotherapeutics (NASDAQ: MLTX) following allegations that the company misled its stakeholders about the potential of its drug, sonelokimab (SLK). The legal landscape is growing heated with a lawsuit alleging violations of securities laws against the company and...
Continue Reading
How AI Unlimited Group’s Lever App Transforms Student Loan Management
Revolutionizing Student Loan Management with AI AI Unlimited Group Inc. (OTCQB: AIUG), based in Los Angeles, has launched a groundbreaking tool called the Lever App, designed specifically for student loan borrowers. This innovative app is making waves by addressing the persistent issues highlighted by the Consumer Financial Protection Bureau (CFPB) regarding student loan...
Continue Reading
Matinas BioPharma Welcomes New Board Member and Funding Deal
Introduction to Recent Developments at Matinas BioPharma Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) is making headlines with its latest announcement about a major agreement involving the acquisition of preferred stock and the appointment of a new board member. This strategic move promises to bolster the company's position as a leading biopharmaceutical entity...
Continue Reading